Protocol Compliance [GxP / QC / QA]

posted by Dr.Sridhar – 2010-04-03 13:04 (5918 d 15:12 ago) – Posting: # 5007
Views: 6,972

Dear Raghavendra,

It will be better to safety analysis to be on safer side because this will prove that subject lost to follow up was due to his personal problems or not due to any Adverse event with your drug.

And you can also file an protocol deviation for same with proper explanation.

Regards,
Dr.Sridhar


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
174 visitors (0 registered, 174 guests [including 35 identified bots]).
Forum time: 04:16 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5